185 related articles for article (PubMed ID: 22431782)
21. Migratory necrolytic erythema and glucagonoma.
Echenique-Elizondo M; Elorza JL; De Delas JS
Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
[No Abstract] [Full Text] [Related]
22. [Necrolytic migratory erythema. A marker of systemic disease].
de Cristancho NP; Rivera J; de Arriaga AD
Rev Clin Esp; 1994 Aug; 194(8):654. PubMed ID: 7938851
[No Abstract] [Full Text] [Related]
23. Necrolytic migratory erythema: an important sign of glucagonoma.
Cui M; Wang R; Liao Q
Postgrad Med J; 2021 Mar; 97(1145):199. PubMed ID: 32527759
[No Abstract] [Full Text] [Related]
24. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
Chaw L; Krop TM; Hood AF
Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
[No Abstract] [Full Text] [Related]
25. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
[TBL] [Abstract][Full Text] [Related]
26. Glucagonoma syndrome with severe erythematous rash: A rare case report.
Wang ZX; Wang F; Zhao JG
Medicine (Baltimore); 2019 Sep; 98(37):e17158. PubMed ID: 31517863
[TBL] [Abstract][Full Text] [Related]
27. Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.
Toberer F; Hartschuh W; Wiedemeyer K
Am J Dermatopathol; 2019 Mar; 41(3):e29-e32. PubMed ID: 30124507
[TBL] [Abstract][Full Text] [Related]
28. The glucagonoma syndrome.
Wynick D; Hammond PJ; Bloom SR
Clin Dermatol; 1993; 11(1):93-7. PubMed ID: 8339206
[No Abstract] [Full Text] [Related]
29. Glucagonoma syndrome: case report and literature review.
Parker CM; Hanke CW; Madura JA; Liss EC
J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
[TBL] [Abstract][Full Text] [Related]
30. Necrolytic migratory erythema due to glucagonoma.
Michels G; Nierhoff D; Steffen HM
Clin Gastroenterol Hepatol; 2010 Aug; 8(8):A18. PubMed ID: 20060072
[No Abstract] [Full Text] [Related]
31. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
Oberkirchner U; Linder KE; Zadrozny L; Olivry T
Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
[TBL] [Abstract][Full Text] [Related]
32. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
33. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
34. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
35. Is necrolytic migratory erythema due to glucagonoma a misnomer? A more apt name might be mucosal and intertriginous erosive dermatitis.
Grewal P; Salopek TG
J Cutan Med Surg; 2012; 16(2):76-82. PubMed ID: 22513058
[TBL] [Abstract][Full Text] [Related]
36. [The glucagonoma syndrome].
Levitskaia ZI; Balabolkin MI; Gordina AA; Goriainova II; Tatochenko KV
Sov Med; 1985; (9):120-3. PubMed ID: 2999999
[No Abstract] [Full Text] [Related]
37. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas.
Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W
J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677
[TBL] [Abstract][Full Text] [Related]
38. [Glucagonoma. A tumor disease with multiple clinical manifestations].
Andersson K; Wängberg B; Tisell LE; Nilsson O; Fjälling M; Forssell-Aronsson E; Ahrén B; Ahlman H
Lakartidningen; 1996 Aug; 93(35):2935-9. PubMed ID: 8815353
[TBL] [Abstract][Full Text] [Related]
39. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
40. [Necrolytic migratory erythema in a patient with a glucagonoma].
Demirbas M; Prens B
Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
